Literature DB >> 16547931

The course of etoposide-induced apoptosis in Jurkat cells lacking p53 and Bax.

Natalie O Karpinich1, Marco Tafani, Timothy Schneider, Matteo A Russo, John L Farber.   

Abstract

Jurkat T-lymphocytes lack p53 and Bax but contain p73 and Bid and are killed by etoposide (ETO). With ETO c-abl is phosphorylated and phosphorylated p73 increased. Translocation of full-length Bid to mitochondria follows, with induction of the mitochondrial permeability transition (MPT) and release of cytochrome c into the cytosol. Pronounced swelling of mitochondria was evident ultrastructurally, and the MPT inhibitor cyclosporin A prevented the release of cytochrome c. Overexpression of Bcl-2 prevented the translocation of Bid, the release of cytochrome c, and cell death. The pan-caspase inhibitor ZVAD-FMK prevented the cell killing, but not the initial release of cytochrome c. An accumulation of tBid occurred at later times in association with Bid degradation. A sequence is proposed that couples DNA damage to Bid translocation via activation of c-abl and p73. Bid translocation induces the MPT, the event that causes release of cytochrome c, activation of caspases, and cell death. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547931     DOI: 10.1002/jcp.20638

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  Targeting nucleolin for better survival in diffuse large B-cell lymphoma.

Authors:  N Jain; H Zhu; T Khashab; Q Ye; B George; R Mathur; R K Singh; Z Berkova; J F Wise; F K Braun; X Wang; K Patel; Z Y Xu-Monette; J Courty; K H Young; L Sehgal; F Samaniego
Journal:  Leukemia       Date:  2017-07-10       Impact factor: 11.528

Review 2.  Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning.

Authors:  S E Meshkani; D Mahdian; K Abbaszadeh-Goudarzi; M Abroudi; G Dadashizadeh; J-D Lalau; M E De Broe; H Hosseinzadeh
Journal:  J Endocrinol Invest       Date:  2019-05-16       Impact factor: 4.256

3.  Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.

Authors:  Mitsutsune Washiro; Masayuki Ohtsuka; Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Takashi Sugimoto; Naohiko Seki; Masaru Miyazaki
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-17       Impact factor: 4.553

4.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

5.  Goniothalamin-induced oxidative stress, DNA damage and apoptosis via caspase-2 independent and Bcl-2 independent pathways in Jurkat T-cells.

Authors:  S H Inayat-Hussain; K M Chan; N F Rajab; L B Din; S C Chow; A Kizilors; F Farzaneh; G T Williams
Journal:  Toxicol Lett       Date:  2009-12-22       Impact factor: 4.372

6.  Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11.

Authors:  S Dhayal; H J Welters; N G Morgan
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

7.  Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons.

Authors:  Mohamad-Yehia El-Mir; Dominique Detaille; Gloria R-Villanueva; Maria Delgado-Esteban; Bruno Guigas; Stephane Attia; Eric Fontaine; Angeles Almeida; Xavier Leverve
Journal:  J Mol Neurosci       Date:  2007-11-27       Impact factor: 3.444

8.  Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism.

Authors:  Stephen Jun Fei Chong; Kartini Iskandar; Jolin Xiao Hui Lai; Jianhua Qu; Deepika Raman; Rebecca Valentin; Charles Herbaux; Mary Collins; Ivan Cherh Chiet Low; Thomas Loh; Matthew Davids; Shazib Pervaiz
Journal:  Nucleic Acids Res       Date:  2020-12-16       Impact factor: 16.971

9.  The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors:  Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

10.  RACK-1 overexpression protects against goniothalamin-induced cell death.

Authors:  S H Inayat-Hussain; L T Wong; K M Chan; N F Rajab; L B Din; R Harun; A Kizilors; N Saxena; M Mourtada-Maarabouni; F Farzaneh; G T Williams
Journal:  Toxicol Lett       Date:  2009-08-19       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.